Clinical Trials
15 trialsNCT07574541 2026-06-05
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
National Institutes of Health Clinical Center (CC)
Phase 2 Not yet recruiting
NCT06906471 2026-06-04
A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Antelope Surgical Solutions, Inc
Phase 1/2 Not yet recruiting
NCT07598032 2026-05-20
iCCaRE
University of Ilorin Teaching Hospital
Phase 3 Not yet recruiting
NCT07316686 2026-05-18
Lutécio
Instituto do Cancer do Estado de São Paulo
Phase 1 Not yet recruiting
NCT07592910 2026-05-18
MOMENT
Prostate Cancer Clinical Trials Consortium
Phase 2 Not yet recruiting
NCT07515651 2026-04-07
MIDAS-SBRT
University Health Network, Toronto
Phase 2 Not yet recruiting
NCT06834204 2026-03-23
ACCESS-PC
Rutgers, The State University of New Jersey
Phase NA Not yet recruiting
NCT07460726 2026-03-10
PRIAPUS-PCa
CancerCare Manitoba
Not yet recruiting
NCT07444983 2026-03-03
Rezvilutamide for High-Risk Prostate Cancer After Surgery
Fujian Medical University Union Hospital
Phase NA Not yet recruiting
NCT07268794 2025-12-08
CONVERT-HB1
Fudan University
Phase 2 Not yet recruiting
NCT06931496 2025-04-17
PROSTIA- BP
Central Hospital, Nancy, France
Phase NA Not yet recruiting
NCT06915909 2025-04-08
Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial
East and North Hertfordshire NHS Trust
Phase NA Not yet recruiting
NCT06855589 2025-03-04
PCS-XII
Charles LeMoyne Hospital
Phase 3 Not yet recruiting
NCT06844513 2025-02-25
URO-ROBOT-2023
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase NA Not yet recruiting
NCT06838520 2025-02-20
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting